Longevity Conferences 2023
Curated list of Longevity Conferences, where you can explore the latest research and developments in the field of aging and longevity.
A recent study suggests that small extracellular vesicles could prevent age-related conditions and promote tissue regeneration.
Aging induces several changes at the cellular level, such as oxidative stress, telomere attrition, or cellular senescence resulting in a decreased functionality of tissues. These changes are the main factors that drive age-related conditions, such as sarcopenia, renal failure, frailty, disability, and mortality. Aging also alters intercellular communication by deregulation of critical signaling pathways. New strategies to delay the degenerative changes associated with aging are extensively researched. Sanz-Ros et al. have presented a new possibility in using small extracellular vesicles (sEVs) obtained from adipose mesenchymal stem cells (ADSCs) of young mice.
Extracellular vesicles are small vesicles released by cells. They mediate the transmission of signaling molecules (proteins, small RNAs, and DNA) between cells, also called intercellular communication. Current data suggests that sEVs derived from multiple stem cell types can promote tissue regeneration. Compared to whole stem cells, sEVs also have many advantages, such as higher stability, no risk of aneuploidy (having missing or extra chromosomes), and a lower chance of causing immune rejection. Therefore, they could provide an alternative therapy for various diseases.
The team of Sanz-Ros et al. treated the muscles and kidneys of old mice with sEVs of young animals. Mice used in this study were of a C57BL/6J background – the most widely used genetically modified mouse models of human disease. They were treated with sEVs at 20 to 24 months of age. Both sexes were used throughout the study. Results of the analyses showed improvement in several parameters usually altered with aging:
ADSC-sEVs reversed age-related structural changes in the kidney and muscle of old mice. Decreased oxidative stress, inflammation, and senescence markers in muscle and kidney were also observed. The predicted epigenetic age was lower in old mice treated with ADSC-sEVs tissues. The metabolome (complete set of organisms metabolites which are small-molecule chemicals) of the old mice also changed to a youth-like one.
The research group suggests that the microRNAs contained in sEVs might be responsible for the observed effects and propose that treatment with young sEVs can promote healthy aging.
Aging induces several changes at the cellular level, such as oxidative stress, telomere attrition, or cellular senescence resulting in a decreased functionality of tissues. These changes are the main factors that drive age-related conditions, such as sarcopenia, renal failure, frailty, disability, and mortality. Aging also alters intercellular communication by deregulation of critical signaling pathways. New strategies to delay the degenerative changes associated with aging are extensively researched. Sanz-Ros et al. have presented a new possibility in using small extracellular vesicles (sEVs) obtained from adipose mesenchymal stem cells (ADSCs) of young mice.
Extracellular vesicles are small vesicles released by cells. They mediate the transmission of signaling molecules (proteins, small RNAs, and DNA) between cells, also called intercellular communication. Current data suggests that sEVs derived from multiple stem cell types can promote tissue regeneration. Compared to whole stem cells, sEVs also have many advantages, such as higher stability, no risk of aneuploidy (having missing or extra chromosomes), and a lower chance of causing immune rejection. Therefore, they could provide an alternative therapy for various diseases.
The team of Sanz-Ros et al. treated the muscles and kidneys of old mice with sEVs of young animals. Mice used in this study were of a C57BL/6J background – the most widely used genetically modified mouse models of human disease. They were treated with sEVs at 20 to 24 months of age. Both sexes were used throughout the study. Results of the analyses showed improvement in several parameters usually altered with aging:
ADSC-sEVs reversed age-related structural changes in the kidney and muscle of old mice. Decreased oxidative stress, inflammation, and senescence markers in muscle and kidney were also observed. The predicted epigenetic age was lower in old mice treated with ADSC-sEVs tissues. The metabolome (complete set of organisms metabolites which are small-molecule chemicals) of the old mice also changed to a youth-like one.
The research group suggests that the microRNAs contained in sEVs might be responsible for the observed effects and propose that treatment with young sEVs can promote healthy aging.